Literature DB >> 32693296

Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo.

Sylwia Sudoł1, Katarzyna Kucwaj-Brysz2, Rafał Kurczab3, Natalia Wilczyńska4, Magdalena Jastrzębska-Więsek4, Grzegorz Satała3, Gniewomir Latacz1, Monika Głuch-Lutwin5, Barbara Mordyl5, Ewa Żesławska6, Wojciech Nitek7, Anna Partyka4, Kamila Buzun8, Agata Doroz-Płonka1, Anna Wesołowska4, Anna Bielawska9, Jadwiga Handzlik10.   

Abstract

In the light of recent lines of evidence, 5-HT6R ligands are a promising tool for future treatment of memory impairment. Hence, this study has supplied highly potent 5-HT6R agents with procognitive effects, which represent an original chemical class of 1,3,5-triazines, different from widely studied sulfone and indole-like 5-HT6R ligands. The new compounds were rationally designed as modifications of lead, 4-(1-(2-chlorophenoxy)ethyl)-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine (1), involving an introduction of: (i) two chlorines at benzene ring and (ii) varied linkers joining the triazine ring to aromatic ethers. Synthesis, in vitro and in vivo biological tests and computer-aided SAR analysis for 19 new compounds were carried out. Most of the new triazines displayed high affinity (Ki < 100 nM) and selectivity towards 5-HT6R, with respect to 5-HT2AR, 5-HT7R and D2R. The crystallography-supported docking studies, including quantum-polarized ligand docking (QPLD), indicated that chlorine atoms may be involved in different type of halogen bonding, however, the linker properties seem to predominately affect the 5-HT6R affinity. 4-[1-(2,5-Dichlorophenoxy)propyl]-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine (9), which displayed: the highest affinity (Ki = 6 nM), very strong 5-HT6R antagonistic action (KB = 27 pM), procognitive effects in vivo in novel object recognition (NOR) test in rats, a very good permeability in PAMPA model and satisfying safety in vitro, was identified as the most potent 1,3,5-triazine agent so far, useful as a new lead for further research.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  1,3,5-Triazine; 5-HT(6) antagonist; Docking QPLD; Halogen bonds; Procognitive; Serotonin receptors

Mesh:

Substances:

Year:  2020        PMID: 32693296     DOI: 10.1016/j.ejmech.2020.112529

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  The Therapeutic Potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study.

Authors:  Jelena Z Penjišević; Vladimir B Šukalović; Deana B Andrić; Relja Suručić; Sladjana V Kostić-Rajačić
Journal:  Appl Biochem Biotechnol       Date:  2022-05-04       Impact factor: 3.094

2.  2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity.

Authors:  Marcin Drop; Vittorio Canale; Séverine Chaumont-Dubel; Rafał Kurczab; Grzegorz Satała; Xavier Bantreil; Maria Walczak; Paulina Koczurkiewicz-Adamczyk; Gniewomir Latacz; Anna Gwizdak; Martyna Krawczyk; Joanna Gołębiowska; Katarzyna Grychowska; Andrzej J Bojarski; Agnieszka Nikiforuk; Gilles Subra; Jean Martinez; Maciej Pawłowski; Piotr Popik; Philippe Marin; Frédéric Lamaty; Paweł Zajdel
Journal:  ACS Chem Neurosci       Date:  2021-03-11       Impact factor: 4.418

Review 3.  Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer's Disease: Can It Work from a Molecular Point of View?

Authors:  Kinga Czarnota-Łydka; Katarzyna Kucwaj-Brysz; Patryk Pyka; Wawrzyniec Haberek; Sabina Podlewska; Jadwiga Handzlik
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.